ArticleFrontiers in neurology2025
Endovascular therapy and medical management of large-core infarcts: prognostic determinants in a retrospective cohort.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Futile recanalization after mechanical thrombectomy in patients with acute ischemic stroke and large ischemic core.Journal of cerebrovascular and endovascular neurosurgery · 2026Article
- Impact of admission hyperglycemia on clinical outcomes in patients with acute large ischemic stroke undergoing endovascular treatment.Diabetology & metabolic syndrome · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To investigate the independent prognostic risk factors in acute ischemic stroke patients with large-core infarcts, including patients beyond standard eligibility thresholds for core volume or ASPECTS and provide evidence for early clinical intervention. Methods: This retrospective cohort study analyzed the clinical data of 96 consecutive patients with large-core infarcts admitted to a regional stroke center between June 2020 and June 2024. Participants were stratified into poor outcome [modified Rankin Scale (mRS) 4-6] and favorable outcome (mRS 0-3) groups based on the 90-day post-intervention assessments. Comparative analyses of the baseline demographics, biochemical parameters, neuroimaging metrics, and treatment modalities were conducted. Univariate analysis followed by multivariate logistic regression was used to identify independent predictors of favorable outcome. A prespecified EVT subgroup analysis was performed, including procedural variables (onset-to-puncture time, puncture-to-recanalization time) and clinical variables in multivariate regression. Results: Among the 96 patients, 17 (17.7%) achieved favorable outcomes (mRS 0-3) and 79 (82.3%) had poor outcomes (mRS 4-6). Multivariable analysis identified four independent predictors of poor outcome: non-receipt of EVT [OR = 10.22, 95% confidence interval (CI): 1.05-99.76], hyperglycemia (per 1 mmol/L; OR = 1.76, 95% CI: 1.10-2.82), and higher platelet count (per 10 Conclusion: EVT significantly improves functional outcomes in large-core infarcts. Preoperative hyperglycemia and elevated platelet count are independent predictors of poor outcomes. These findings support standardized protocols that integrate early EVT with glycemic control and coagulation monitoring in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.